GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regenetp Inc (STU:NJT) » Definitions » Shiller PE Ratio

Regenetp (STU:NJT) Shiller PE Ratio : (As of Jun. 07, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Regenetp Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Regenetp Shiller PE Ratio Historical Data

The historical data trend for Regenetp's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regenetp Shiller PE Ratio Chart

Regenetp Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Regenetp Quarterly Data
Apr18 Jul18 Oct18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Regenetp's Shiller PE Ratio

For the Biotechnology subindustry, Regenetp's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regenetp's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regenetp's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Regenetp's Shiller PE Ratio falls into.



Regenetp Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Regenetp's E10 for the quarter that ended in Mar. 2023 is calculated as:

For example, Regenetp's adjusted earnings per share data for the three months ended in Mar. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=-0.542/127.3478*127.3478
=-0.542

Current CPI (Mar. 2023) = 127.3478.

Regenetp Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201304 -48.384 98.107 -62.805
201307 -72.198 98.557 -93.289
201310 -81.363 98.536 -105.154
201401 -78.171 98.692 -100.869
201404 -60.816 100.023 -77.430
201407 -48.774 100.520 -61.791
201410 -98.231 100.176 -124.876
201501 -30.996 98.604 -40.032
201504 -72.072 99.824 -91.944
201507 -5.000 100.691 -6.324
201510 -9.504 100.346 -12.061
201601 -91.409 99.957 -116.457
201604 -12.774 100.947 -16.115
201607 -21.267 101.524 -26.677
201610 3.178 101.988 3.968
201701 -39.715 102.456 -49.364
201704 -548.138 103.167 -676.611
201707 -20.158 103.278 -24.856
201710 1.277 104.070 1.563
201801 -47.355 104.578 -57.666
201804 -29.951 105.708 -36.082
201807 -18.404 106.324 -22.043
201810 -20.880 106.695 -24.922
201903 -26.108 107.251 -31.000
201906 -20.355 108.070 -23.986
201909 -19.749 108.329 -23.216
201912 -17.100 108.420 -20.085
202003 -8.824 108.902 -10.319
202006 -7.326 108.767 -8.577
202009 -3.821 109.815 -4.431
202012 -5.548 109.897 -6.429
202103 -5.040 111.754 -5.743
202106 -0.838 114.631 -0.931
202109 -0.315 115.734 -0.347
202112 -2.319 117.630 -2.511
202203 -2.152 121.301 -2.259
202206 -0.464 125.017 -0.473
202209 -0.475 125.227 -0.483
202212 -0.123 125.222 -0.125
202303 -0.542 127.348 -0.542

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Regenetp  (STU:NJT) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Regenetp Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Regenetp's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Regenetp (STU:NJT) Business Description

Traded in Other Exchanges
Address
1960 South 4250 West, Salt Lake City, UT, USA, 84104
Regenetp Inc Formerly PolarityTE Inc is a clinical-stage biotechnology company developing regenerative tissue products and biomaterials. It's focused on transforming the lives of patients by discovering, designing, and developing regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences. Its product includes SkinTE used for repair, reconstruction, replacement, or regeneration of the skin in patients who have or require treatment of acute and chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. It operates in two segments: the regenerative medicine business segment and the contract research segment.

Regenetp (STU:NJT) Headlines

No Headlines